Position in MRNA
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$2,621,993
+$882,144 QoQ
Shares Held
37,441
+9.3% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#201
of 772 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rakuten Investment Management, Inc. holds $59,330,921 across 7 Biotechnology names. MRNA ranks #5 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
61,183 | $30,391,431 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
24,580 | $15,326,613 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
17,961 | $5,406,799 | |
| 4 | INCY |
Incyte Corp
|
27,525 | $3,120,234 | |
| 5 | MRNA |
Moderna, Inc.
This page
|
37,441 | $2,621,993 | |
| 6 | INSM |
INSMED Inc
|
12,109 | $1,291,061 | |
| 7 | TECH |
BIO-TECHNE Corp
|
16,600 | $1,172,790 |
All Filings in MRNA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,621,993 | 37,441 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $1,739,849 | 34,249 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $914,514 | 31,011 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $102,906 | 3,984 | Shares | Sole | 2025-10-30 | |
| 2025-03-31 | $868,445 | 30,633 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $1,849,921 | 27,681 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $2,420,125 | 20,380 | Shares | Sole | 2025-05-15 | |
| 2024-03-31 | $1,333,918 | 12,518 | Shares | Sole | 2025-05-15 | |
| 2023-12-31 | $80,952 | 814 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||